Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation (Q4979239)

From MaRDI portal
Revision as of 15:55, 8 July 2024 by ReferenceBot (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article; zbMATH DE number 6305022
Language Label Description Also known as
English
Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation
scientific article; zbMATH DE number 6305022

    Statements

    Modeling the impact of hepatitis C viral clearance on end‐stage liver disease in an HIV co‐infected cohort with targeted maximum likelihood estimation (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    17 June 2014
    0 references
    0 references
    double-robust
    0 references
    inverse probability of treatment weighting
    0 references
    Kaplan-Meier
    0 references
    longitudinal data
    0 references
    marginal structural model
    0 references
    survival analysis
    0 references
    targeted maximum likelihood estimation
    0 references
    0 references
    0 references
    0 references
    0 references